Related Experiment Video
Updated: Aug 14, 2026
11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Increase of hypothalamic cholinergic activity in 2-deoxyglucose hyperglycemia
A Takahashi1, H Ishimaru, Y Ikarashi
1Department of Neuropsychopharmacology (Tsumura), Gunma University School of Medicine, Japan.
Neuroscience Letters
|December 5, 1994
Summary
Administration of 2-deoxyglucose (2-DG) increases choline and decreases acetylcholine (ACh) in rat hypothalamus nuclei, suggesting a role for cholinergic neurons in 2-DG-induced hyperglycemia.
Area of Science:
- Neuroscience
- Endocrinology
- Biochemistry
Background:
- Hyperglycemia, a condition of high blood sugar, can be induced by 2-deoxyglucose (2-DG).
- The hypothalamus plays a crucial role in regulating glucose homeostasis.
- Cholinergic neurotransmission is implicated in various physiological processes, including metabolic regulation.
Purpose of the Study:
- To investigate the role of hypothalamic cholinergic neurons in 2-deoxyglucose (2-DG)-induced hyperglycemia.
- To analyze the changes in choline and acetylcholine (ACh) levels in specific hypothalamic nuclei following 2-DG administration.
Main Methods:
- Induction of hyperglycemia in rats via intravenous administration of 2-deoxyglucose (2-DG).
- Microdissection of microwave-fixed rat brains to isolate specific hypothalamic nuclei: ventromedial hypothalamic nucleus (VMH), lateral hypothalamus (LH), and paraventricular nucleus (PVN).
- Quantification of choline and acetylcholine (ACh) content in the isolated hypothalamic nuclei.
Main Results:
- 2-DG administration led to a significant increase in choline content within the VMH, LH, and PVN.
- Acetylcholine (ACh) levels decreased in the lateral hypothalamus (LH) and paraventricular nucleus (PVN).
- In adrenodemedullectomized rats, the hyperglycemic response to 2-DG was attenuated, while choline levels in the LH were further elevated.
Conclusions:
- Hypothalamic cholinergic neurons contribute to the hyperglycemic effects induced by 2-deoxyglucose (2-DG).
- The observed changes in choline and ACh suggest a complex interplay between cholinergic signaling and glucose regulation in the hypothalamus.
- These findings provide insights into the neurochemical mechanisms underlying glucose metabolism and hyperglycemia.
Related Concept Videos
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...